Mouth Ulcer Treatment Market Size To Rise USD 2.19 Bn By 2032

Published Date : 14 Dec 2023

The global mouth ulcer treatment market size exceeded USD 1.55 billion in 2023 and is expected to rise to USD 2.19 billion by 2032, growing at a CAGR of 3.9% during the forecast period.

Mouth Ulcer Treatment Market Size and Growth Rate From 2023 To 2032

Market Overview

Mouth ulcer appears anywhere inside the mouth. Mouth ulcers are usually small sores that develop on the gums, lips, inner cheeks, tongue, or roof of mouth. These sores are mostly yellow, red, or white. There are several causes of these mouth ulcers factors such as emotional stress, lack of sleep, certain nutritional deficiencies, trauma due to hard brushing, hormonal changes, accidental bites, and some other allergies or infections. Most mouth ulcers clear up by themselves within the period of one to two weeks. Mouth ulcers are common diseases and at times can be managed at home without treatment.

Most mouth ulcers can heal from OTC products within one to two weeks. Several over-the-counter (OTC) products, such as oral gels, mouthwashes, and others provide relief. However, treatment from a specialized doctor can help to alleviate swelling as well as ease any discomfort. Treatment becomes necessary when an individual suffers from recurrent and non-healing mouth ulcers or mouth ulcer that affects eating and drinking.

To diagnose and treat mouth ulcers, an individual can visit a general physician and dentist. The drugs required for the treatment of mouth ulcers such as Topical anesthetics, Sucralfate, Steroids, Multivitamins, Mouthwashes containing dexamethasone, GERD drugs, Antiseptics, Antipyretics and Analgesics, and Antibiotics.

Growth Factors

The growth of the mouth ulcer treatment market is driven by several factors including the growing geriatric population, increasing consumption of tobacco, rapid adoption of novel treatment options, growth in unhealthy lifestyles, increasing patient accessibility to essential treatment, and increasing awareness regarding oral hygiene. Additionally, the rising incidence of people suffering from oral and dental problems owing to the consumption of synthetic chemicals in foods and dental care products is the prime major factor fueling the global mouth ulcer treatment market.

  • In November 2023, a new fund the 4100 Group Inc. started with an initial $35 million investment targets deals toward innovations in dental and oral health. The investment from an unnamed strategic investor provides an anchor limited partner for Arcis Fund I that Lansing-based the 4100 Group hopes to grow significantly to as large as $100 million.
  • In the October 2023, it is estimated 60 % of the world’s population has experienced such mouth ulcers during their lifetime as it is a common disorder. Mucocort, a Swedish MedTech company announced its plans to launch a mucosal self-absorbing patch for pain relief in people suffering from aphthous stomatitis (mouth ulcers). The interest in Mucocort patch technology has increased after the approval of a European patent.
  • In May 2023, Delta Dental of Colorado Foundation (DDCOF) announced four grants totaling nearly USD 5 million dedicated to expanding and diversifying dental hygiene programs across the state in partnership with Colorado's higher education system.
  • In February 2023, H2Ocean announced that the recent clinical study concluded that H2Ocean's alcohol-free sea salt mouthwashes provide a proven effective remedy for dry mouth and Xerostomia. Published in the Journal of Biological Regulators & Homeostatic Agents, the study's findings call H2Ocean's mouthwashes a recommended alternative to the armamentarium of treatment options for xerostomia and dry mouth syndrome.

Regional Insights

North America is expected to hold the largest market share over the forecast period. The growth of the region is attributed to the increasing prevalence of mouth ulcers, sophisticated healthcare infrastructure, rising aging population, increasing development of advanced drugs, increasing investment in research & development activities, and increasing awareness among individuals regarding the availability of effective mouth ulcer treatments. Prominent competitors in the industry, including Blistex, Inc., Church & Dwight Co., Inc., 3M, Colgate-Palmolive Company, Bristol Myers Squibb Company, Pfizer, Inc., and Patterson Dental Supply Inc., are characteristics of the US market.

Several market players are aggressively investing in research and development activities to develop innovative and advanced treatment drugs for mouth ulcers.  Additionally, pharmaceutical companies in the country are committed to providing novel and more efficacious treatments for mouth ulcers which has been a major factor in driving market dynamics. The rising adoption of advanced technology including digital X-rays, intra-oral cameras, and optical scanners is likely to propel the growth of the market in the region.

Furthermore, a very renowned company Colgate-Palmolive Company has unveiled over-the-counter products that help in healing and reducing the pain of mouth ulcers such as Colgate Plax, a mouthwash that is alcohol-free formula not only cleanses the mouth but also soothes the irritation, even in sensitive mouths. Thus, the development of a wide range of mouth ulcer care products and an increase in mouth ulcer cases are projected to propel the market growth in the region.

Mouth Ulcer Treatment Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 1.55 Billion
Projected Forecast Revenue by 2032 USD 2.19 Billion
Growth Rate from 2023 to 2032 CAGR of 3.9%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Market Dynamics

Drivers

Increasing awareness regarding dental and oral hygiene

The rising awareness regarding dental and oral hygiene among the population is expected to fuel the market’s growth in the coming years. Several campaigns are conducted on dental and oral hygiene in rural areas of developing and underdeveloped countries. The key market players and reputed institutions are focusing on R&D activities that assist in the treatment of mouth ulcers. Due to an ongoing awareness regarding dental and oral hygiene has been increased launches of mouthwashes.

Several different non-medicated and medicated mouthwashes are used for maintaining oral hygiene and alleviating pain as well as inflammation from canker sores. For instance, In May 2022, SmartMouth launched the SmartMouth Mouth Sore Oral Rinse. The new Mouth Sore Activated Mouthwash helps to reduce minor irritation, sore mouth, pain, sore throat, and canker sores. The product is designed to also deliver the same patented zinc ion formula to prevent bad breath for 24 hours with just two rinses a day.

Increasing prevalence of mouth ulcer

The prevalence of mouth ulcers is expected to fuel the mouth ulcer treatment market during the forecast period. The cases of mouth ulcers have risen due to various factors such as stress, allergy, hormonal changes, infection, accidentally biting, citrus fruits, minor injury, and nutrient deficiencies, particularly vitamin B9 (folate), zinc, vitamin B12, and iron.

In addition, the consumption of tobacco and chemical-based toothpaste containing sodium lauryl sulphate has led to increasing demand for mouth ulcer treatment products. Mouth ulcers are a common disease globally and the cases are increasing rapidly year by year. For instance, as per the secondary sources, it is estimated about 1 in 10 individuals. Depending on the severity of mouth ulcers they can be classified into different types such as minor mouth ulcers (account for 85% of the cases), major mouth ulcers (account for about 10% of the cases), and herpetiform mouth ulcers.

Furthermore, Cancer of the mouth can first appear as a mouth ulcer. Ulcers caused by cancer usually appear on or under the tongue or may appear somewhere else in the mouth. An increase in mouth ulcers cases can be a sign of mouth cancer too. According to the American Cancer Society's 2023 report for oral cavity and oropharyngeal cancers in the U.S. and nearly 54,540 new cases of oral cavity or oropharyngeal cancer and roughly 11,580 deaths from oral cavity or oropharyngeal cancer. Thus, increasing of prevalence mouth ulcer is also likely to be boost the market’s growth during the forecast period.

Restraint

Adverse effects of using oral ulcer treatment products

Adverse effects associated with the use oral ulcer treatment products is projected to hamper the growth of the mouth ulcer treatment market. Products such as steroid mouthwash or tablets. Hydrocortisone buccal tablets are corticosteroids that relieve the soreness of ulcers but it includes common adverse effects such as headache, diarrhea, dizziness, and indigestion. In addition, During the forecast period, the mouth ulcers treatment market's expansion is anticipated to be constrained by the low healthcare budget in undeveloped and developing countries will impede the market’s growth. In these countries, pharmaceutical firms have limited sources for research and development of targeted medicines.

Opportunity

Rising geriatric population

The rising geriatric population is expected to fuel the market’s expansion during the forecast period as the aging demographic is more susceptible to mouth ulcers. As per the United Nations World Social Report 2023, the number of persons aged 65 years or older across the globe is projected to double over the next three decades. The rising cases of age-related diseases have spurred the demand for ointments and medications used to treat mouth ulcers. Additionally Eating a good diet that is rich in vitamins A, C, and E, and wide adoption of pharmaceutical drugs are all factors driving forces in the expansion of the mouth ulcers treatment market.

Technological advancements and new product launches

The robust growth in technological advancement is projected to fuel the market’s expansion in the coming years. The Key players are investing in the development of advanced technology. The increasing use of digital X-rays, digital intraoral optical scanner, and intra-oral in the field of dentistry is propelling the market’s growth. For instance, In April 2022, Envista Holdings Corporation announced the acquisition of Carestream Dental's Intraoral Scanner business. This acquisition is likely to help Envista's long-term strategy to focus on the fastest growing segments of the dental market and to create differentiated solutions via the digitalization of dental workflows.

In addition, the new product launches are also projected to witness the fastest growth during the forecast period. For instance, In September 2022, ICPA Health Products ltd., a leader in the oral-health segment unveiled an anti-ulcer dental paste “Trioplast”. Trioplast is an oral anti-ulcer dental paste for treating mouth ulcers. Mouth ulcers are painful sores which causes difficulties to eat and drink. When the paste is applied in the affected area it provides relief from swelling and redness. Thereby driving the market’s growth.

Recent Developments

  • In September 2022, Mucocort AB is a swedish company of oral patches for aphthous stomatitis. The company announced the partnership with medical technology company Aurena Laboratories AB. The collaborate of these two companies will focus on production, marketing, sales, and an intended international market launch.
  • In November 2022, Acteon introduced its most advanced intraoral camera, the next-generation C50 which provides dental professionals with sharp images to improve dental treatment workflows as well as offers greater diagnostic flexibility and enhanced patient benefits.

Key Market Players

  • 3M Company
  • Blistex Inc.
  • GSK plc
  • Church & Dwight Co. Inc.
  • Colgate-Palmolive Company
  • Patterson Dental Supply Inc.
  • Pfizer Inc.
  • Dr. Reddy's Laboratories Ltd
  • Prince Care Pharma Private Limited
  • Bristol Myers Squibb Company

Market Segmentation

By Drug Class

  • Antimicrobial
  • Antihistamine
  • Analgesics & Corticosteroids
  • Others

By Formulation

  • Sprays
  • Mouthwash
  • Gels
  • Lozenges

Buy this Research Report@ https://www.precedenceresearch.com/checkout/3409

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308